🔗 Share this article

Chancellor Reeves has stated she is preparing "targeted action to deal with cost of living issues" in the upcoming financial statement.

In comments to the BBC, she emphasized that curbing inflation is a collective duty of both the administration and the central bank.

The United Kingdom's inflation rate is forecast to be the most elevated among the G7 industrialized countries this calendar year and the following year.

Potential Energy Cost Measures

Reports indicate the government could intervene to bring down energy bills, such as by reducing the current 5% level of VAT charged on energy.

Another possibility is to reduce some of the regulatory levies presently added to bills.

Budgetary Limitations and Analyst Predictions

The administration will obtain the next draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much space there is for these actions.

The expectation from the majority of analysts is that the Chancellor will have to introduce tax increases or expenditure reductions in order to fulfill her self-imposed debt limits.

Earlier on the same day, estimates indicated there was a £22 billion deficit for the chancellor to address, which is at the more modest range of projections.

"It is a shared responsibility between the Bank of England and the government to further reduce some of the causes of price increases," Reeves informed the BBC in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Revenue Pledges and International Concerns

While a great deal of the focus has been on probable tax increases, the chancellor said the latest figures from the OBR had not changed her pledge to manifesto promises not to raise rates on earnings tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with rising international and trade issues for the Budget revenue measures, likely to be focused on those "most able to pay."

International Economic Disputes

Addressing worries about the UK's economic relations with China she said: "The UK's security interests invariably take priority."

Last week's declaration by China to strengthen trade restrictions on critical minerals and other resources that are crucial for advanced tech manufacturing led US President Donald Trump to threaten an extra 100% tariff on goods from the Asian country, raising the possibility of an all-out commercial conflict between the two global powers.

The American finance chief labeled China's decision "commercial pressure" and "a international production control attempt."

Asked about considering the American proposal to participate in its dispute with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and called on the Chinese government "not to put up barriers and limit trade."

She said the move was "damaging for the international commerce and creates further headwinds."

"I believe there are areas where we should confront China, but there are also significant opportunities to export to China's economy, including banking sector and other sectors of the economy. We've got to get that balance appropriate."

The Treasury chief also stated she was collaborating with other major economies "regarding our own essential resources approach, so that we are reduced dependence."

Health Service Drug Pricing and Investment

Reeves also recognized that the price the National Health Service spends on medicines could increase as a result of ongoing talks with the US government and its drugs companies, in exchange for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either halting or canceling operations in the United Kingdom, with several attributing the low prices they are getting.

Last month, the government science advisor said the cost the health service pays for drugs would need to go up to prevent firms and pharmaceutical investment leaving the UK.

Reeves told media: "We have seen because of the cost structure, that drug testing, innovative medicines have not been provided in the United Kingdom in the manner that they are in other continental states."

"The objective is to make sure that individuals receiving treatment from the NHS are able to access the best critical treatments in the world. And so we are reviewing this situation, and... aiming to attract more investment into Britain."